Earnings Labs

Quaker Chemical Corporation (KWR)

Q3 2020 Earnings Call· Sat, Nov 7, 2020

$138.97

-1.15%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.
Transcript

Operator

Operator

Greetings. Welcome to Quaker Houghton Third Quarter 2020 Investor Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Michael Barry, Chairman, CEO, and President. Thank you. You may begin.

Michael Barry

Analyst

Good morning, everyone. Joining me today are Mary Hall, our CFO; Robert Traub; our General Counsel; and Shane Hostetter, our Head of Finance and Chief Accounting Officer. We have slides for our conference call. You can find them in the Investor Relations section of our website at www.quakerhoughton.com. A great deal has changed in the world in 2020 with the COVID-19 pandemic. For us, our top priority is and has been to protect the health and safety of our employees and our customers, while ensuring our business continuity to meet our customers' requirements. All of our 34 plants around the world are operating, and we are satisfying all of our customer needs. I am very proud of what the Quaker Houghton team has done to continuing to service our customers, as well to continue our integration efforts, which are going well. We are pleased with our results for the third quarter when considering we were coming from such a weak second quarter. Overall, our sales were up sequentially 28% from the second quarter and down 5% from the third quarter of last year on a pro forma basis. Let me now give you a little more flavor on what we experienced by segment or region. First, as we look sequentially, the Americas saw the largest quarterly net sales improvement as sales grew 48% sequentially, driven primarily by stronger volumes. A similar story I heard in Asia Pacific, EMEA, and our Global Specialty Businesses, where volume improvement drove net sales increases of 24%, 21% and 16% respectively compared to the second quarter. So we saw good sequential improvement in all business segments. Another way to indicate this sequentially quarterly sales trend is to look at what happened in our three main customer industry groups on a global basis. Metalworking increased the…

Mary Hall

Analyst

Thank you, Mike. And good morning all. Before I begin, let me remind you that comments made during this call include forward-looking statements, which are based on current expectations, estimates, projections and assumptions that are subject to risks and uncertainties, which may cause actual results to differ materially. For a discussion of these risks, please review the cautionary statements regarding forward-looking statements included in our earnings release and in our 2019 Form 10-K filed with the SEC. These are available on our website. Please also note that we continue to update our risk factors in our Form 10-Q to address the evolving COVID-19-related issues, and these risk factors should be reviewed along with those in our 2019 Form 10-K. In our press release and in this presentation, we provided certain information, including non-GAAP earnings per diluted share, non-GAAP operating income and adjusted EBITDA as well as certain pro forma items in an effort to provide shareholders with better visibility into the company's core operations, excluding certain items, which we believe do not reflect our core operating performance. Reconciliations are provided in the appendix of this investor deck. In this review, our comparison periods show actual and non-GAAP results, as well as pro forma sales and pro forma adjusted EBITDA as if we've been combined with Houghton throughout the periods presented. Remember that we closed the Combination on August 1, 2019, so our actual reported and non-GAAP Q3 2019 results include only two months of Houghton. Please see slides six through 10 now, while I review some highlights. As Mike noted, we saw sales rebound of $367 million in the third quarter, up 28% from $286 million in Q2, but still down 5% from pro forma Q3 2019 sales of $386 million, due primarily to lower volumes as a result of…

Michael Barry

Analyst

Thank you, Mary. We'll now open it up for questions.

Operator

Operator

Thank you. [Operator Instructions] Our first question is from Mike Harrison with Seaport Global Securities. Please proceed.

Mike Harrison

Analyst

Hi, good morning.

Michael Barry

Analyst

Good morning, Mike.

Mary Hall

Analyst

Good morning.

Mike Harrison

Analyst

Congratulations on a nice quarter, and I hope they're counting your ballots, as we speak.

Michael Barry

Analyst

I think they are.

Mike Harrison

Analyst

I was wondering if you can talk a little bit about what's driving the confidence in your 2021 EBITDA outlook. Obviously, you increased the synergy assumptions and that's contributing, but what are you assuming around the rate of recovery in some of your key markets, and I guess, what are your thoughts on the potential impact of the second COVID wave?

Michael Barry

Analyst

Sure. Yeah, it's hard to know obviously exactly what a second COVID wave will do and what the lockdowns that are going now in Europe and how they'll impact things. We're basing our 20%-plus kind of increase on really there's a gradual increase from where we kind of are today in our markets. We expect on top of that to continue to get our market share gains in that 2% or over like we normally get. But we hopefully will not have a similar instance that we had in the second quarter of this year, which is a pretty severe drop. And so, if you kind of eliminate that, have kind of gradual improvement in your markets, have -- continue with your -- our synergy achievements and kind of do the math on that and it's that. But you're right, I mean if something else happen from a COVID perspective and the world lock down again and becomes worse than maybe what projections are for orders and steel, then that could impact that, but this is just based on what our best estimates at this time.

Mike Harrison

Analyst

All right. And then, wanted to ask about the steel business, we've seen a little bit of consolidation with Cleveland Cliffs and AK Steel as well as our ArcelorMittal's U.S. assets. Can you talk about what that consolidation means for your steel business?

Michael Barry

Analyst

Both of those customers are very significant customers to us. In some ways, switching - probably we'll switch our largest customer from being ArcelorMittal to the AK Steel Group or the closed group. So - but essentially we don't expect to see any difference. We have very strong relationships with those customers and we don't anticipate any impact on our business because of that.

Mike Harrison

Analyst

Wanted to ask about the Americas business, it really seems like the margin performance there was a lot stronger than what we are anticipating and obviously a massive improvement on a year-over-year basis. Can you give maybe a little bit more color about what drove that margin strength, particularly in the Americas?

Michael Barry

Analyst

The Americas, we have, I would say a disproportionate amount of raw material savings. Our raw material savings that we're achieving are disproportionate and more of it in the Americas than in other regions or business segments. So that's one aspect. We also had - we're doing our manufacturing consolidations. We've been pretty conservative or ensuring that we don't disrupt supply. So we have taken these shutdowns and while [ph] to make sure we plan them properly and transition materials and so forth before we shut down a certain plant. Most of those shutdowns happened in the first wave of manufacturing consolidation, really happened in late in the second quarter, and of course in the Americas, we saw some of that too, but that's really everywhere around the world basically. But when you add those two impacts together, I think it's - you just see - tend to see more of it in the gross margin area in the Americas and other places.

Mike Harrison

Analyst

All right. And then last question for me for now is just a clarification on the EBITDA guidance. You're talking that Q4 EBITDA should look similar to Q3, which was $64 million. By my math, that would put you above $220 million for the full year and you're guiding to more than $215 million. I'm aware that $220 million is more than $215 million, but just wondering should we be looking for Q4 to be more like high 50s than the $64 million you did in Q3? Or do you feel like it exceeds $64 million?

Michael Barry

Analyst

I think it's just reflective of sometimes maybe our conservative nature, but also the uncertainty that we see in the marketplace right now. For example, we have -- we're having lockdowns take place in Europe now. How will that eventually impact and could that, for example, make some of the seasonality impacts that we see at the end of the year be more extended or customers may shut down, we don't know yet. So I think it's just kind of reflective of the uncertainty in there, but we were trying to at least give you kind of a range of where things could fall out.

Mike Harrison

Analyst

Understood. All right, thanks very much.

Michael Barry

Analyst

Thank you, Mike.

Operator

Operator

Our next question is from Laurence Alexander with Jefferies. Please proceed.

Dan Rizzo

Analyst

Hey, guys. It's Dan Rizzo on for Laurence. How are you?

Michael Barry

Analyst

Good. Good morning, Dan.

Mary Hall

Analyst

Good morning, Dan.

Dan Rizzo

Analyst

Have you guys identified any Houghton revenue synergies yet and I missed it? I mean, is there any - kind of any - anything out there on that?

Michael Barry

Analyst

Yes, we are getting synergies. We haven't really pointed them amount or quantified them per se, but when I do say that we are getting net market share gains of 2% this quarter versus like say the third quarter of last year, part of that is due to the cost synergies that we're achieving -- not the cost synergies, the sales synergies that we're achieving due to the Combination.

Dan Rizzo

Analyst

Okay. That's helpful. And then on the cost synergies and a temporary cost reductions, I was wondering how much of the temporary cost reductions will be coming back next year and when and how much that will be offsetting or how that will offset the synergies you're looking for from Houghton and just from general productivity?

Michael Barry

Analyst

Sure. And that's a great question and I think a lot of that will probably depend upon how quick COVID goes away. For example, right now, it's very difficult for us to travel a lot. And so we do expect, for example, especially in the second half of the year hopefully getting back to a more normal situation next year, but -- so some will come back. We hope that, but when I mentioned about our EBITDA being 20%-plus next year, that kind of takes into account those things that not only the additional synergies but also takes some additional costs that'd come back just because of getting back hopefully to a more normal business environment.

Mary Hall

Analyst

If I would just - hey, Dan, let me chime in there if I could just add to that. So when we talk about increasing the cost synergy estimate, that is only permanent what we view is permanent costs included in that. So -- and any temporary cost reductions, as Mike mentioned, we've attempted to factor into the overall adjusted EBITDA guidance.

Dan Rizzo

Analyst

Okay. All right. Thank you very much.

Michael Barry

Analyst

Thanks, Dan.

Operator

Operator

[Operator Instructions] Our next question is from Jon Tanwanteng with CJS Securities. Please proceed.

Jon Tanwanteng

Analyst

Hi, good morning and congratulations on the quarter.

Michael Barry

Analyst

Thanks. Good morning, Jon.

Jon Tanwanteng

Analyst

Good morning. I may have missed this, but I was wondering did you give any specific color on real-time demand in October and then heading into November as these cases spike and lockdown come in and if you've given any specific cushion for yourselves in the guidance for Q4 and maybe early next year as we run through the course of this.

Michael Barry

Analyst

I think I guess we did not comment specifically on October. I mean I think it's -- things are progressing like we expect it to be. To me, again, as I kind of mentioned in the previous question that was asked that to me the more wildcard is it's not necessarily December or November, it's going to be more - sorry, October or November, it's going to be more of a December issue and something happen there. So I think - I do think our guidance that we mentioned has a range and that indicates that one part December could be weaker and that will be something closer to that $215 million kind of number that we talked about. And then if it's not and we continue to progress and things are let's say more normal, then it could be higher than that.

Jon Tanwanteng

Analyst

Got it. That's helpful. And then a question for Mary, you've thrown out the kind of cash, it's kind of a function of your business model. I'm just wondering if any of that reverses out as the business recovers, you have to put more into working capital. How should we think about cash flow going forward with that as a context?

Mary Hall

Analyst

Sure. And typical working capital dynamics and sales continue to pick up. Obviously, the receivables will follow, but we're also showing good inventory management and overall good working capital management. So when we look at that on a percent of sales basis, again, we will continue to manage that prudently. And while we would expect not true that as the business really begins to pick up that we'll be investing in working capital as opposed to releasing cash from working capital, we would still expect to see good positive cash flow as earnings pick up corresponding to the sales and volume pickup.

Jon Tanwanteng

Analyst

Okay, fair enough. And then last one for Mike, you've been delivering on these higher and higher synergies roughly about every six months or so. I mean where are they all coming from? Is that low-grade or runouts, should we be expecting more as you dive deeper into the business, especially if you can travel more between locations and business tick back up?

Michael Barry

Analyst

Sure. So I think initially there were kind of two major drivers we had. Early on, the raw material synergies and some of the supply chain synergies weren't able to be identified as good in the planning efforts just because we had to operate in a clean room environment. And then, we saw that they were going to be greater as we got into the actual execution of those And then what - I think what you're seeing now more recently is an acceleration of putting our synergies into place. So even if you take what we have today, and you say, $17 million this quarter multiplied by four, we're at a $68 million kind of run rate with that. So I think it's just showing that we're accelerating faster than we had. And then the other element in here too is that when we -- as we went through the COVID situation, that hit us starting in March, April time frame, we kind of re-looked at a few things in light of the situation and in light of -- and learning about things being within the Combination in the first nine months and then decided to make even some additional changes as well. So I think it's a combination of those things that have caused us to increase.

Operator

Operator

Okay. And we do have a follow-up from Mike Harrison with Seaport Global Securities. Please go ahead.

Mike Harrison

Analyst

Hi. Just a couple of questions on maybe digging into some of your end markets. Can you talk a little more about your aerospace exposure? I know you have the chemical milling maskants business within Global Specialty. But is there exposure in other products or other regions that you'd consider to be aerospace? And then is that -- is it all commercial, is there some military or business jet? And then how much of that is maintenance versus new aircraft production?

Michael Barry

Analyst

So yeah, most of what -- I'd say the majority -- vast majority of what we do is new rather than maintenance, and you're right, the maskants business is certainly a significant part of it for new aircraft builds, but we also do have - we're in a metalworking fluids that get used in the production of NIM aircraft as well predominantly in U.S. and Europe. So overall - all those things have been impacted. Right now, we're looking at the aerospace being in a roughly around 3% of our sales, and we don't really see much potential increase in our - in that particular market for a while. I said the other markets will come back probably over the next one to two years. I think it will take much longer for aerospace to come up but that kind of gives you a magnitude but I think what we're seeing and experiencing right now is probably towards the bottom of that market at this point.

Mike Harrison

Analyst

All right. And then over on the tube and pipe business, is that something that just remains weak until oil and gas activity improves? Or have you seen some pick up there?

Michael Barry

Analyst

Yeah. We have - it's been weak and probably - and I would say it's weaker now than it was in the past certainly just because of the overall situation, but we have seen some positives in the business as well recently, but we're certainly closer to our low point at this point, given where oil is.

Mike Harrison

Analyst

All right. And then last, wanted to ask about the canning business. We're hearing that there are shortages and a lot of those can producers are running flat out to meet demand, they're talking about adding capacity. Are there things that you're doing to help those customers run harder? Does it mean that they're using higher-end products from you guys? Or are they just using more of them, if they're running at a 100% capacity?

Michael Barry

Analyst

Yeah. I think in general, of course, what our products try to do is make our customers' processes more efficient and productive. So -- but I would say, in general, I don't know if there's been any major changes in that, I think we've seen benefits in our business over the past couple of years. We've been taking share in that business because of our products and our customers are operating pretty much flat out at this point. So I agree with your assessment on that. And I think it's just going to be a matter of time as they try to put on more capacity over time and that should help our business as well.

Mike Harrison

Analyst

All right, thanks very much.

Michael Barry

Analyst

Thanks, Mike.

Operator

Operator

We have reached the end of our question-and-answer session. I would like to turn the conference back over to management for closing remarks.

Michael Barry

Analyst

Okay. Given there are no other questions, we will end our conference call now, and I want to thank all of you for your interest today. Our next conference call for the fourth quarter will be in late February or early March of 2021. And if you have any questions in the meantime, please feel free to reach out Mary or myself. Thanks again for your interest in Quaker Houghton.

Operator

Operator

Thank you. This does conclude today's conference. And thank you for your participation. Have a wonderful day.